Pharmaceutical

STAT+: ARCH Venture Partners is raising $3 billion for ...

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is rai...

STAT+: The lessons of Aduhelm, Biogen’s Alzheimer’s dru...

Aduhelm, a pioneering treatment for Alzheimer’s that collapsed under corporate m...

Lead aprons not necessary for patients during X-rays, s...

Lead aprons and vests aren't necessary for patients during X-rays, according to ...

Chicago children’s hospital network down as experts war...

Lurie Children’s was forced to take its network down after a security incident a...

STAT+: Senate working group proposes 340B reforms

A group of senators released a draft of proposed legislation to clarify controve...

STAT+: AI therapy and ICU training: A first look at hea...

Exclusive: Apple works with Cedars-Sinai , Boston Children’s Hospital to develop...

STAT+: Pharmalittle: We’re reading about opioid settlem...

A division of the Publicis Groupe and Hikma Pharmaceuticals reached separate set...

What makes a drug a blockbuster — or a cautionary tale?

Though Aduhelm's last rights had arguably already been read before Biogen retire...

Opinion: Can Arena Bioworks upend the traditional scien...

Can Arena Bioworks upend the traditional scientific research model in the U.S.?

Texas Medical Board under pressure to define emergency ...

Two high-profile abortion supporters filed a petition seeking to clarify the gro...

Promising red-light myopia treatment for children is ra...

The benefits of a red-light laser treatment for myopia may come at the risk of c...

Opinion: Medicare has different standards than the FDA....

Medicare has different standards than the FDA. That’s how it should be.

As England’s virus hospitalisations surge flu vaccines ...

England evaluates vaccine procurement and pandemic preparedness, whilst Moderna’...

Scottish company secures £4.2m to advance 3D-printed mi...

Carcinotech has gained funding to enter the North American market with the compa...

LimmaTech secures funding for vaccine technology develo...

LimmaTech announced the closing of a second round of its Series A financing, sec...

Biosyngen’s liver cancer therapy receives fast track de...

The US Food and Drug Administration (FDA) has granted fast track designation (FT...